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Abstract
Background: Microtubule-targeting drugs induce mitotic delay at pro-metaphase by preventing the spindle assembly
checkpoint to be satisfied. However, especially after prolonged treatments, cells can escape this arrest in a process called
mitotic slippage. The mechanisms underlying the spindle assembly checkpoint and slippage are not fully understood. It has
been generally accepted that during mitosis there is a temporary shutdown of high-energy-consuming processes, such as
transcription and translation. However, the synthesis of specific proteins is maintained or up-regulated since protein
synthesis is necessary for entry into and progression through mitosis.
Methodology/Principal Findings: In this work we investigated whether the mitotic arrest caused by the mitotic checkpoint
is independent of transcription and translation. By using immunofluorescent microscopy and western blotting, we
demonstrate that inhibition of either of these processes induces a shortening of the mitotic arrest caused by the nocodazole
treatment, and ultimately leads to mitotic slippage. Our western blotting and RTQ-PCR results show that inhibition of
transcription during mitotic arrest does not affect the expression of the spindle checkpoint proteins, whereas it induces a
significant decrease in the mRNA and protein levels of Cyclin B1. The exogenous expression of Cyclin B1 substantially
rescued the mitotic phenotype in nocodazole cells treated with the inhibitors of transcription and translation.
Conclusions/Significance: This work emphasizes the importance of transcription and translation for the maintenance of the
spindle assembly checkpoint, suggesting the existence of a mechanism dependent on cyclin B1 gene regulation during
mitosis. We propose that continuous transcription of mitotic regulators is required to sustain the activation of the spindle
assembly checkpoint.
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Introduction
The spindle assembly checkpoint (SAC), or mitotic checkpoint,
monitors the microtubule attachment to kinetochores, ensuring
the correct segregation of chromosomes [1,2]. Therefore, this
mechanism prevents sister chromatids separation, delaying the
onset of anaphase, until all kinetochores are correctly attached to
the mitotic spindle and under appropriate tension. Unattached
kinetochores trigger a diffusible signal [2,3], the mitotic checkpoint
complex (MCC), that inhibits the Anaphase Promoting Complex/
Cyclosome (APC/C) by acting as a pseudo-substrate of APC/C
(reviewed in ref. [4]). Besides Mad2, BubR1, Bub3 and Cdc20,
that compose the MCC [5], several other proteins, including other
SAC proteins (e.g. Mad1, Mps1 and Bub1) play an important role
in the recruitment and establishment of the MCC (reviewed in ref.
[4]). Once the proper attachment of all kinetochores to the mitotic
spindle occurs, the SAC becomes satisfied and is inactivated. The
Cdc20 activates the APC/C which promotes the ubiquitination of
several mitotic substrates, including Cyclin B1 and Securin, that
will be subsequently degraded by the proteasome (reviewed in ref.
[6]).
Spindle poisons disturb the dynamics of microtubules (MTs),
either by depolymerisation (e.g. nocodazole) or by stabilization
(e.g. taxol; at high concentration induces polymerization) [7,8],
resulting in lack of attachment from the kinetochores. Conse-
quently, the SAC remains activated and cells are arrested in pro-
metaphase. The duration of mitotic delay depends on several
factors, including the organism, the cell type and the initial
concentration of the spindle poison (reviewed in ref. [9]).
However, especially after prolonged treatments, cells may
overcome the mitotic delay, even in the presence of the drug,
and cycle into G1 without achieving cytokinesis, in a process
named mitotic slippage [8,9,10,11,12]. Therefore, the nuclear
envelope reforms around random groups of chromosomes as the
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cleated and tetraploid. Even though the molecular details that
underlie mitotic slippage are not fully understood, Cyclin B
degradation and the consequent inactivation of the cyclin-
dependent kinase 1 (CDK1) has been shown to play an important
role [13].
During mitosis, there is a temporary shutdown of high-energy-
consuming processes, such as transcription and translation. The
concept of a lack of transcription in mammalian cells during
mitosis has been generally accepted for more than 40 years
(reviewed in ref. [14]). Similarly, the rate of protein synthesis
decreases in mitosis. However, the synthesis of specific proteins are
maintained or up-regulated since protein synthesis is necessary for
entry into and progression through mitosis (reviewed in refs.
[15,16]). Contrary to the widely accepted notion that transcription
is repressed during mitosis in higher eukaryotes, the active
transcription of cyclin B1 gene during mitosis has been proposed
in HeLa cells [17]. Here, we investigated whether SAC is
independent of de novo transcription and translation processes.
Our results indicate that both transcription and translation of
Cyclin B1 are required for the sustained activation of the SAC.
Results
Inhibition of transcription and translation induces mitotic
slippage
In the presence of an active SAC, treatment with drugs that
disturb microtubule assembly, such as nocodazole, causes cell-
cycle arrest in pro-metaphase [7], but the molecular details behind
such event are not completely clarified. We investigated whether
the mitotic delay caused by treatment with spindle poisons could
occur independently of transcription and translation. NIH3T3
cells were incubated for 14 h with nocodazole and further treated
for 4 h with either 35.5 mM of cycloheximide (CHX), a de novo
protein synthesis inhibitor [18], or 8 mM of actinomycin D (ActD),
an inhibitor of transcription [19]. Morphological visualization by
phase-contrast microscopy showed that, in comparison to
nocodazole-arrested cells (noc-cells; incubated with nocodazole
for 18 h), both CHX treated noc-cells (noc-CHX cells) and ActD
treated noc-cells (noc-ActD cells) lost the rounded morphology
characteristic of mitotic cells and became flat and adherent
(Fig. 1A). Furthermore, microtubule staining showed loss of
disassembled mitotic spindle (characteristic of nocodazole treat-
ment) and DNA staining with DAPI revealed the presence of
multinuclei and/or micronuclei (Fig. 1B; arrowheads indicate
mitotic cells whereas arrows show multinucleated cells). This
morphology is in agreement with previous description of cells that
slipped through mitosis, namely after a prolonged mitotic delay in
the presence of spindle poisons [11,12,20]. Calculation of the
mitotic index by analysis of condensed chromosomes showed that
noc-cells presented a index of approximately 50% whereas after
treatment with CHX or ActD the mitotic index decreased to
values of approximately 10%, corresponding to a fold decrease of
approximately 80% (p,0.01, noc-CHX and noc-ActD cells
compared to noc-cells) (Fig. 1C). Both the CHX and ActD
treatments induced almost 40% increase in the number of
multinucleated cells in the total cell population. Hence, we
observed that the length of the SAC was reduced, increasing the
number of cells that escape mitosis (Fig. 1). (Note that a small
number of noc-cells also slipped after the 18 h treatment with
nocodazole [Fig. 1B and C]). The effect of inhibition of
transcription and translation in the SAC length was also addressed
in the human cell line HEK293 (Fig. 2). HEK293 cells were
incubated for 14 h with nocodazole and further treated for 6 h
with either 35.5 mM of CHX or 8 mM of ActD. Again, calculation
of the mitotic index revealed a statistically significant decrease in
noc-CHX and noc-ActD cells compared to noc-cells (p,0.01 and
p,0.005 respectively) (Fig. 2B).
These results suggest that transcription and translation are
required to maintain cells arrested in mitosis and that pharma-
cological inhibition of either process can reduce the length of the
SAC inducing mitotic slippage.
Inhibition of transcription and translation results in the
activation of the APC/C
Inactivation of the SAC normally leads to the activation of the
APC/C
Cdc20 (reviewed in ref. [4]). In order to address whether the
APC/C
Cdc20 was activated during the slippage caused by
inhibition of transcription or translation we blocked 26S protea-
some-dependent degradation using the pharmacological inhibitor
MG132. As previously demonstrated in other systems [13,21],
exposure to MG132 prevented mitotic slippage induced by CHX
and ActD (data not shown).
Next, we investigated if two substrates of APC/C
Cdc20, Cyclin
B1 and Securin, were being degraded. Treatment of noc-cells with
ActD or CHX for 4 h resulted in the decrease of both Cyclin B1
and Securin at protein levels, revealed by western blotting (Fig. 3A,
lane 3 and 6 compared to lane 2). Figure 3B shows the
quantification of Cyclin B1 and Securin protein levels. Staining
of Cyclin B1 and Securin by immuno-fluorescence microscopy
(Fig. 3C and D) confirmed that cells that slipped mitosis (indicated
by arrows) contain lower amounts of Cyclin B1 and Securin than
mitotic cells (indicated by arrowheads). Incubation with the
proteasome inhibitor MG132 restored the levels of Cyclin B1
and Securin (Fig. 3A, lanes 4 and 7). We next analysed the levels of
CDK1 that have been shown to decrease in other systems of
mitotic slippage [11]. However, the levels of CDK1 remained
unaffected, despite the absence of transcription or translation
during mitotic delay (Fig. 3A). Together, our data suggests that
inhibition of transcription and translation during SAC arrest
induced by nocodazole results in the activation of the APC/C
Cdc20
and the subsequent degradation of Securin and Cyclin B1. These
results are in concordance with recent observations of activation of
APC/C during mitotic slippage [22].
Inhibition of transcription affects cyclin B1 gene
expression
Since it has been described previously that translation of specific
proteins is maintained or up-regulated during mitosis [15], we
hypothesized that both transcription and translation of at least one
protein responsible for the mitotic delay would occur during
mitosis. Previously, it has been shown that cells depleted of Mad2,
Bub3, Rae1, BubR1 or CENP-E are unable to sustain a pro-
metaphase arrest in the presence of spindle damage [23,24].
Furthermore, deregulation of spindle checkpoint proteins can
induce premature mitotic exit, even in the presence of spindle
drugs [20,25,26]. In order to address if inhibition of transcription
would affect the expression of spindle checkpoint transcripts,
bubR1, bub3, mad1, mad2 and cdc20 gene expression were analysed
by real-time quantitative PCR. The result showed that Bub3
mRNA levels significantly decreased (p,0.05) in the presence of
ActD, whereas the levels of Cdc20, Mad1, Mad2 and BubR1
transcripts did not display significant differences (Fig. 4A).
Reduction in Bub3 mRNA has been reported in cells upon
prolonged exposure to taxol, and been proposed as a cause to the
mitotic slippage [11]. As a result, we next investigated if the
decrease of Bub3 transcripts was associated with a parallel
Transcription and Mitosis
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the APC/C
Cdc20. Contrary to what happens at the mRNA level,
western blotting analysis showed no relevant change in the protein
levels of Bub3 from noc-CHX or noc-ActD cells (Fig. 4B and C,
lanes 3 and 6 compared to 2). The reason for this is unclear;
however, it is possible that the Bub3 protein pool has a low
turnover and, therefore, is not affected by the inhibition of bub3
transcription.
To confirm that the negative effect of inhibition of transcription
on the expression of SAC transcripts analysed was also reflected at
the protein level, we analysed the protein levels of Mad2.
Consistent with the lack of variation observed at the transcrip-
tional level, inhibition of transcription and translation did not
significantly affect the protein levels of Mad 2 (Fig. 4D and E, lanes
3 and 6 compared to lane 2).
Given that Cyclin B1 and Securin protein levels were down-
regulated, we next investigated if inhibition of transcription was
affecting the expression of cyclin B1 and Pttg (the gene that codes for
Securin) genes. To this end, mRNA was isolated from a
population of cells synchronized at the G1/S boundary with
thymidine (Thy), noc-cells, noc-ActD cells and noc-ActD-MG
cells, and the levels of Cyclin B1 and Securin transcripts analysed
by real-time quantitative PCR. The result showed a significant
decline (p,0.05) in the mRNA levels of Cyclin B1 when
Figure 1. Mitotic slippage is induced in nocodazole-treated cells after inhibition of transcription or translation. Characterization of
NIH3T3 cells: control cells, nocodazole (noc)-treated cells (arrested in mitosis), noc-cells incubated with cycloheximide (CHX; 35.5 mM) or actinomycin
D (ActD; 8 mM) for 4 h. A) Phase-contrast microscopy; magnification: 2006. B) Immunofluorescence microscopy; arrowheads indicate mitotic cells and
arrows indicate cells that underwent mitotic slippage; DAPI stains the DNA (blue) and anti-a-tubulin antibody stains the microtubules (green). Scale
bar =25 mm. C) Mitotic and multinucleation indexes of noc-treated cells with or without CHX or ActD for 4 h. Data presented as mean 6 S.D. from
three independent experiments; ** p,0.01 noc-CHX or noc-ActD versus noc.
doi:10.1371/journal.pone.0013037.g001
Transcription and Mitosis
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levels of Securin transcripts did not show significant differences
(Fig. 5).
To further investigate the role of Cyclin B1 expression in the
maintenance of the SAC activation we attempted to rescue the
mitotic phenotype by transient transfection of HEK293 cells with
wild type and non-degradable forms of Cyclin B1 (CyclinB1-wt
and CyclinB1-R42A, respectively), using as control pCMS-EGFP
(Fig. 6). The transfection efficiency was approximately 50%, and
all subsequent analyses were performed in the mixed population of
transfected and non-transfected cells. Western blotting analysis
revealed that treatment of noc-cells with ActD or CHX for 6 h
resulted in the decrease of endogenous Cyclin B1 protein levels but
did not affect the exogenous expression of Cyclin B1 (Fig. 6B and
C; lanes 5 and 6 compared to lane 4 in panel B, lanes 4 and 5
compared to lane 3 in panels C; endogenous Cyclin B1 indicated
with an asterisk whereas exogenous Cyclin B1 is indicated with a
double asterisk). Moreover, the decrease of endogenous Cyclin B1
protein in CyclinB1 transfected cells was similar to the one
observed in pCMS-EGFP transfected cells. Calculation of the
mitotic index revealed that, upon treatment with ActD or CHX,
cells transfected with either CyclinB1-wt or CyclinB1-R42A
approximately doubled the mitotic figures present in the cells
transfected with pCMS-EGFP (p,0.05 and p,0.005) (Fig. 6D),
rescuing the mitotic phenotype. Notably, the standard deviation
observed may result from differences in the transfection efficiency.
Also, the transfection efficiency of 50% may be preventing a more
substantial rescue of the mitotic phenotype. This result indicates
that if Cyclin B1 protein levels are increased within the cell, during
the same period of time, there are less cells slipping mitosis.
Overall our data suggest that inhibition of transcription and
translation induces the inactivation of SAC by affecting the
expression of Cyclin B1.
Discussion
Here, we show that both transcription and translation are
required for the maintenance of the mitotic delay. We show that
four and six hours of treatment with actinomycin D or
cycloheximide is sufficient to override the mitotic delay caused
by nocodazole in NIH3T3 and HEK293 cells, respectively, and
induce slippage. The mechanism underlying slippage in our
system seems to be independent of changes in the expression of
Mad1, Mad2, BubR1, Cdc20, Securin and Bub3, although Bub3
mRNA levels were affected upon inhibition of transcription but no
significant change was observed at the protein level. Our results
suggest that the mechanism underlying the activation of the APC/
C
Cdc20 upon mitotic inhibition of transcription or translation
involves cyclin B1 gene expression.
Our work questions the prevailing model of the general
inhibition of transcription during mitosis (reviewed in ref.[14]),
since we clearly show that pharmacological inhibition of
transcription during mitotic delay results in the abrogation of
the mitotic delay. However, our work is in accordance with the
observation that transcription of cyclin B1 is active during mitosis
[17]. The decrease of Cyclin B1 mRNA levels upon inhibition of
transcription during mitotic delay and the mitotic phenotype
rescue by overexpression of Cyclin B1 protein indicate that
Cyclin B1 expression during mitosis indeed is crucial for the
sustained activation of theSAC.Althoughwecannot excludethe
Figure 2. Inhibition of transcription or translation induces mitotic slippage in nocodazole treated HEK293 cells. Characterization of
HEK293 cells: control cells, nocodazole (noc)-treated cells (arrested in mitosis), noc-cells incubated with cycloheximide (CHX; 35.5 mM) or actinomycin
D (ActD; 8 mM) for 6 h. A) Phase-contrast microscopy; magnification: 2006. B) Mitotic index of noc-treated cells with or without CHX or ActD for 6 h.
Data presented as mean 6 S.D. from three independent experiments; ** p,0.01 and *** p,0.005 noc-CHX or noc-ActD versus noc.
doi:10.1371/journal.pone.0013037.g002
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Analysis of Cyclin B1, Securin and CDK1 levels by western blotting. NIH3T3 cells were incubated with nocodazole (noc) for 14 h and treated with
actinomycin D (ActD; 8 mM) or cycloheximide (CHX; 35.5 mM) with or without the inhibitor of the proteasome MG132 (25 mM), for 4 h; b-actin was
used as loading control. B) Quantification of Cyclin B1 and Securin proteins in noc-, noc-ActD-, noc-ActD-MG, noc-CHX and noc-CHX-MG-cells.
Normalization of Cyclin B1 and Securin was calculated on the ratio of these proteins per b-actin protein present in each condition. Data presented as
Transcription and Mitosis
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mechanism underlying the mitotic slippage induced by inhibi-
tion of transcription or translation through relocation, our
results do indicate that this mechanism is independent of
changes in the expression of the spindle checkpoint proteins
analysed.
The proposal of the requirement of Cyclin B1 expression during
mitosis for the sustained activation of the SAC fits within the
Figure 4. Expression of Mad1, Mad2, BubR1 and Cdc20 are not affected by inhibition of transcription, whereas Bub3 transcript
levels are affected but Bub3 protein is not. A) Real time quantitative PCR analysis of several spindle checkpoint transcripts (Mad1, Mad2, BubR1,
Bub3 and Cdc20) present in nocodazole (noc) cells treated with or without the inhibitor of transcription actinomycin D (ActD; 8 mM), for 4 h. Results
from each gene amplification were normalized using L19 expression and presented as fold increase from nocodazole cells. Data presented as mean 6
S.D. from three independent experiments; * p,0.05 noc-ActD versus noc. B and D) Western blotting analysis of Bub3 (B) and Mad2 (D) in nocodazole
(noc) cells treated with ActD or cycloheximide (CHX; 35.5 mM) in the presence or absence of the proteasome inhibitor MG132 for 4 h; b-actin was
used as loading control. C and E) Quantification of Bub3 (C) and Mad2 (E) protein in noc-, noc-ActD- and noc-CHX-cells. Normalization of Bub3 or
Mad2 was calculated on the ratio of these proteins per b-actin protein present in each condition. Data presented as mean 6 S.D. from three
independent experiments.
doi:10.1371/journal.pone.0013037.g004
mean 6 S.D. from three independent experiments. C and D) Immunofluorescence microscopy: asynchronous population (control) and noc-cells
treated with ActD for 4 h; DAPI stains the DNA (blue) and Cyclin B1 (C) and Securin (D) are stained in green. Arrowheads point mitotic cells and arrows
point cell that undergone mitotic slippage. The adapted cells shown are representative of both ActD and CHX induced mitotic slippage. Scale bar
=25mm.
doi:10.1371/journal.pone.0013037.g003
Transcription and Mitosis
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been proposed based on the observation of a slow but continuous
proteasome-dependent proteolysis of Cyclin B, in the presence of
an active SAC. In the presence of microtubule targeting drugs
SAC cannot be satisfied and bypassing an active SAC requires
proteasome-mediated proteolysis of Cyclin B1 to escape mitosis.
The continuous degradation model proposes that, in vertebrate
cells, the SAC would not efficiently block all APC/Cs from
ubiquitinating Cyclin B, leading to a gradual drop of Cyclin B
until it reaches a level lower than the needed to maintain the
mitotic delay [13]. We extend this model and propose that the
decrease in the Cyclin B1 mRNA levels observed in our data by
inhibition of transcription may contribute to a further decrease in
the levels of the protein pool, additional to that caused by the
leakage proteolysis. Upon inhibition of transcription, the minimal
threshold of Cyclin B1 needed to maintain the mitotic delay is
more rapidly reached, resulting in the activation of the APC/
C
Cdc20 and the consequent active ubiquitination of Cyclin B1 and
Securin, targeting these substrates for proteasome degradation.
This hypothesis is further substantiated with our observation that
inhibition of proteasome degradation does not prevent the
decrease of Cyclin B1 mRNA levels upon inhibition of
transcription, despite preventing the decrease of protein levels.
Therefore, upon inhibition of proteasome degradation, inhibition
of transcription or translation has no impact in the levels of Cyclin
B1 protein pool, and accordingly, mitotic slippage no longer
occurs.
Reinforcing this theory, we have shown that by increasing
Cyclin B1 protein levels within the cells, fewer cells slip mitosis
when transcription and translation are inhibited. One could expect
a better rescue of the mitotic phenotype if the transfection
efficiency was higher than 50%. However, we do not exclude the
possibility that other protein(s) can play a role in the maintenance
of the SAC and may also be regulated at the transcriptional and
translational level during mitosis.
The requirement of protein synthesis during mitosis has already
been proposed [15,27,28]. Recently, the continuous protein
synthesis of Cdc20 in mitosis has been reported [28]. However,
in our system the levels of Cdc20 mRNA do not change
significantly when transcription is inhibited, excluding a role for
Cdc20 in the induction of mitotic slippage. Although unclear, it is
possible such discrepancy might result from different cell types
used, namely human HeLa cells as opposed to murine NIH3T3
cells. To our knowledge, we present here the first experimental
data that support the requirement of both transcription and
translation for the sustained activation of the SAC, showing that at
least cyclin B1 gene expression is required. We propose that the
maintenance of the SAC requires continuous transcription of
mitotic driving regulators.
Materials and Methods
Cell culture, cell-cycle synchronization and cell
treatments
NIH3T3 and HEK293 cells were cultured at 37uC, under 5%
CO2, in DMEM (Dulbecco’s modified Eagle’s medium) with
GlutaMAX
TM-I and 1000 mg/L glucose, supplemented with 10%
(v/v) heat-inactivated FBS (foetal bovine serum) and 1% (v/v)
penicillin-streptomycin (all reagents from Invitrogen). G1/S
phases or G2/M phases-arrested cells were obtained after a 14 h
treatment of an asynchronous population of cells with 2.5 mM
thymidine (Sigma) or with 800 nM of nocodazole (Tocris),
respectively. The treatments with actinomycin D (8 mM; Sigma),
cycloheximide (35.5 mM; Sigma) and MG132 (25 mM; Tocris)
were performed at 37uC for 4 h for NIH3T3 and for 6 h for
HEK293 cells. All NIH3T3 and HEK293 cells were analyzed
after 18 h and 20 h treatment, respectively. The drugs used were
titrated and the minimal concentration of inhibition chosen.
Immunofluorescence microscopy
NIH3T3 and HEK 293 cells were seeded on coverslips pre-
treated with poly-L-lysine. Cells were washed with PBS and fixed
with either 100% (v/v) methanol for 7 min at –20uC for
subsequent immunofluorescence with a-Tubulin or with 4% (w/
v) PFA (paraformaldehyde; Merck) for 20 min at room temper-
ature for Cyclin B1 and Securin. After PBS washing from the
fixative, cells were permeabilized with PBS-0.1% (v/v) Triton
X100 for 3 min at room temperature, and blocked with PBS-3%
(w/v) BSA for 30 min at room temperature. The primary
antibodies were diluted in PBS-3% (w/v) BSA to a final
concentration of 1:200 (mouse anti-a-Tubulin, Sigma) or 1:50
(mouse anti-Cyclin B1, Santa Cruz Biotechnology; mouse anti-
Securin, Abcam) and incubated for 1 h at room temperature.
Afterwards, cells were washed with PBS-0.01% (v/v) Tween 20
(Sigma) and incubated with anti-mouse-A488 antibody (Molecular
Probes) diluted 1:500 in PBS-3% (w/v) BSA. Cells were washed
with PBS and counterstained with DAPI (49,6-diamino-2-pheny-
lindole dihydrochloride; 100 ng/ml; Sigma) for 5 min at room
temperature. Coverslips were mounted on glass slides using
Vectashield (Vector) mounting medium and sealed with nail-
polish. Preparations were observed on a Leica DMRA2 fluores-
cence microscope with an objective of 1.4 numerical aperture and
photographed with a Photometrics Cool Snap HQ Camera.
Images were processed using Image J software (version 1.32a).
Figure 5. Inhibition of transcription results in the decrease of
Cyclin B1 mRNA levels, but do not affect Securin’s transcripts.
Analysis of the level of transcripts of Cyclin B1 and Securin by real-time
quantitative PCR. mRNA was isolated from a G1/S enriched population
of cells treated with thymidine (Thy), and from nocodazole- arrested
cells (noc-cells) treated with or without actinomycin D (ActD; 8 mM) and
MG132 for 4 h. Results from Cyclin B1 and Securin amplification were
normalized using L19 expression and presented as fold increase of
Cyclin B1 or Securin expression from noc-cells. Data presented as mean
6 S.D. from three independent experiments; *** p,0.005; ** p,0.01;
*p ,0.05 Thy or Noc+ActD or Noc+ActD+MG versus Noc.
doi:10.1371/journal.pone.0013037.g005
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DNA from NIH3T3 and HEK293 cells were stained with DAPI
in a procedure similar to the described above. The mitotic index
was measured by counting the number of cells with condensed
chromosomes, and percentages calculated. Cells with more than
one nucleus were counted as multinucleated cells. At least 4 fields
comprising a total number of <100 cells were analyzed for each
measurement. Slides were observed on a Leica DMRA2
fluorescence microscope.
Protein extraction and Western blotting
All reagents except those specifically mentioned were purchased
from Sigma. Cells were lysed in cold lysis buffer [25 mM HEPES,
5 mM MgCl2, 1 mM EGTA and 0.5% (v/v) Triton X-100,
pH 7.5, supplemented with 2 mM NaF (sodium fluoride), 50 mM
b-glycerol phosphate, 1 mM DTT (dithiothreitol), 2 mM PMSF
(phenylmethanesulfonyl fluoride), 2 mg/ml aprotinin, 1.5 mg/ml
benzamidine, 2 mg/ml leupeptin and 1 mg/ml pepstatin A] and
centrifuged at 20000 x g for 15 min at 4uC. After protein
quantification by the Bradford method using the Bio-Rad Protein
Assay reagent (Bio-Rad), proteins were boiled at 100uC for 5 min
with 6x SDS (sodium dodecyl sulphate) sample buffer [350 mM
Tris/HCl, pH 6.8, 10% (w/v) SDS, 30% (v/v) glycerol, 0.6 M
DTT, 0.12 mg/ml bromophenol blue]. Proteins were then
analysed on 8–15% SDS-PAGE gels, and electroblotted onto
nitrocellulose (Scheicher & Schuell) or PVDF (polyvinylidene
fluoride; Bio-Rad) membranes. Membranes were blocked with
PBS- 5% (w/v) non-fat dried milk for 1 h at room temperature
and incubated for 1 h at room temperature or overnight at 4uC
with mouse anti-Cyclin B1 (1:200; [GNS1]; Santa Cruz
Biotechnology), mouse anti-Cdc2/p34/CDK1 (1:200; [17]; Santa
Cruz Biotechnology), mouse anti-Securin (1:200; [DCS-280];
Abcam), mouse anti-Bub3 (1:1000; BD Transduction Laborato-
ries), or mouse anti-b-Actin (1:1000; Sigma) in blocking solution.
Membranes were then repeatedly washed with PBS with 0.1%
Tween 20 and incubated with anti-mouse-HRP antibody diluted
1:1000 (Zymed Laboratories) for 1 h to overnight and washed with
PBS. Detection of the signal was achieved using the ECLH
(enhanced chemiluminescence) kit (Amersham Biosciences) ac-
cording to the manufacturer’s instructions. For antibody removal,
membranes were incubated with stripping solution (62.5 mM
Tris.HCl, pH 6.8, 0.5% (v/v) SDS, 0.875% (v/v) b-mercaptoeth-
anol) for 30 min at 56uC and washed in PBS.
Real-Time Quantitative PCR analysis
Total RNA was isolated from NIH3T3 using TrizolH reagent
(Invitrogen
TM) and cDNA synthesis was performed using M-
MuLV reverse transcriptase (Fermentas) according to manufac-
turer’s instructions. cDNA from NIH3T3 cells was amplified
using primers for mouse sequences of Bub3 (sense: 59-
Figure 6. Overexpression of Cyclin B1 protein rescues the mitotic phenotype. HEK293 cells were transfected with the wild-type and the
non-degradable forms of Cyclin B1 (CyclinB1-wt and CyclinB1-R42A, respectively); pCMS-EGFP was used as transfection control. A, B and C) Analysis of
Cyclin B1 endogenous (indicated with one asterisk) and exogenous (indicated with double asterisk) protein levels by western blotting in cells
transfected with pCMS-EGFP (A), CyclinB1-wt (B) and CyclinB1-R42A (C). After transfection, HEK293 cells were incubated with nocodazole (noc) for
14 h and treated with actinomycin D (ActD; 8 mM) or cycloheximide (CHX; 35.5 mM) for 6 h; b-actin was used as loading control. All lanes presented in
C are from the same experiment. D) Mitotic index of nocodazole (Noc) treated cells with or without CHX or ActD for 6 h. Data presented as mean 6
S.D. from three independent experiments; *** p,0.005 and *p,0.05 noc-CHX or noc-ActD from cells transfected with Cyclin B1 versus noc-CHX or
noc-ActD from cells transfected with pCMS-EGFP.
doi:10.1371/journal.pone.0013037.g006
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GATGGAGCT-39), BubR1 (sense: 59-CGGGACGCAG GCC-
TC-39; antisense: 59-TGGGAAGCACGCTGGG-39), Cdc20
(sense: 59-CGATTT GCACTCACTGCTTCA-39; antisense: 59-
CAGCGCGCAACCGG-39), Cyclin B1 (sense: 59-TGTGTG-
AACCAGAGGTGGAA-39; antisense: 59- CGGGCTTGGAGA-
GG GATTAT-39), Mad1 (sense: 59-ACTAGCCGTGGCCT-
CTGCT-39; antisense: 59-CAT CCCCAGTAGCTTGCTCC-
39), Mad2 (sense: 59-GGTAGTGTTCTCCGTTCGATCT AG-
T-39; antisense: 59-GCAGGGTGATGCCTTGCT-39), Securin
(sense: 59-TGAATG AAGAGAGAGGGCTGG-39; antisense: 59-
AAAGGGTGTCTTCAGAGGGCTA-39) and L19 (sense: 59-
GGAAAAAGAAGGTCTGGTTGGA-39; antisense: 59-TGATC-
TG CTGACGGGAGTTG-39). L19 expression served as internal
control and was used to normalize for variances in input cDNA.
Primers were designed using the ABI Primer Express software and
their specificity confirmed using NCBI BLAST module. Detection
of the expression of each gene was performed with SYBR Green
(Applied Biosystems) in an ABI PRISM 7700 Sequence Detection
System (Applied Biosystems), using the relative standard curve
method. All measurements were performed in triplicate.
Plasmids and transient transfections
YFP-CyclinB1-wt (kindly provided by Dr. R. Medema, Utrecht
Medical Center, Utrecht, the Netherlands), GFP-CyclinB1-R42A
(kindly provided by Dr. J Pines, The Wellcome Trust/Cancer
Research UK Gurdon Institute, Cambridge, United Kingdom
[29]), and pCMS-EGFP were used to transiently transfect
HEK293 cells.
Twenty four hours before transfection, HEK293 cells were
seeded at a density of 4610
5 cells per well in a 6 well-plate dishes,
pre-treated with poly-L-lysine. Transfection of plasmid DNA
(700 ng) was carried out using Lipofectamine 2000 (Invitrogen)
according to the protocol provided with the product. Nineteen
hours after the beginning of the transfection, cells were subjected
to nocodazole treatment for 14 h. Further treatments with
actinomycin D and cycloheximide were performed for 6 h at
37uC.
Statistical analysis
Data are expressed as mean 6 SD and were analysed for
significance using Student’s t test for comparison between two
groups. P-values are as follows: *** p,0.005, ** p,0.01 and
*p ,0.05. All experiments were performed for at least three times.
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